dipyridamole has been researched along with Diabetes Mellitus, Type 1 in 25 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
Diabetes Mellitus, Type 1: A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence.
| Excerpt | Relevance | Reference |
|---|---|---|
| ", aspirin alone (330 mg 3 times daily) or in combination with dipyridamole (75 mg 3 times daily), was tested versus placebo in 475 patients with early diabetic retinopathy." | 9.06 | Effect of aspirin alone and aspirin plus dipyridamole in early diabetic retinopathy. A multicenter randomized controlled clinical trial. The DAMAD Study Group. ( , 1989) |
| " Following a three week course of aspirin (330 mg)--dipyridamole (75 mg) taken three times daily there was significant reduction in exercise-induced albuminuria (expressed as the ratio of albumin excretion rate during exercise to that at rest before exercise) when compared to administration of placebo (P less than 0." | 9.06 | Reduction of exercise-induced albuminuria by aspirin-dipyridamole in patients with diabetes mellitus. ( Davies, JA; Hopper, AH; Tindall, H; Urquhart, S, 1987) |
| ", aspirin alone (330 mg 3 times daily) or in combination with dipyridamole (75 mg 3 times daily), was tested versus placebo in 475 patients with early diabetic retinopathy." | 5.06 | Effect of aspirin alone and aspirin plus dipyridamole in early diabetic retinopathy. A multicenter randomized controlled clinical trial. The DAMAD Study Group. ( , 1989) |
| " Following a three week course of aspirin (330 mg)--dipyridamole (75 mg) taken three times daily there was significant reduction in exercise-induced albuminuria (expressed as the ratio of albumin excretion rate during exercise to that at rest before exercise) when compared to administration of placebo (P less than 0." | 5.06 | Reduction of exercise-induced albuminuria by aspirin-dipyridamole in patients with diabetes mellitus. ( Davies, JA; Hopper, AH; Tindall, H; Urquhart, S, 1987) |
| "To assess coronary blood flow velocity in young patients with type 1 DM using transoesophageal Doppler echocardiography with dipyridamole and to analyse the possible relationship between the impairment of coronary flow and retinopathy as well as microalbuminuria." | 3.74 | Association between retinopathy, microalbuminuria and coronary perfusion in young patients with type 1 diabetes mellitus. ( Biegalski, W; Dankowski, R; Kandziora, M; Michalski, M; Naskret, D; Poprawski, K; Wierzchowiecki, M, 2008) |
| "Pravastatin treatment, resulting in decreased LDL oxidation, did not improve myocardial perfusion reserve in subjects with type 1 diabetes." | 2.71 | Effect of pravastatin on low-density lipoprotein oxidation and myocardial perfusion in young adults with type 1 diabetes. ( Ahotupa, M; Janatuinen, T; Knuuti, J; Nuutila, P; Raitakari, OT; Rönnemaa, T; Toikka, JO, 2004) |
| "A total of 21 men with Type 1 diabetes were investigated, including 9 men with background retinopathy and 12 men without retinopathy." | 2.71 | Diabetic background retinopathy is associated with impaired coronary vasoreactivity in people with Type 1 diabetes. ( Janatuinen, T; Knuuti, J; Nuutila, P; Raitakari, OT; Rönnemaa, T; Sundell, J; Toikka, J, 2004) |
| "The patients with IDDM had normal exercise echocardiography and autonomic nervous function tests." | 1.30 | Coronary flow reserve is reduced in young men with IDDM. ( Iida, H; Knuuti, J; Koskinen, PJ; Laine, HK; Lehtimäki, TJ; Nuutila, P; Pitkänen, OP; Raitakari, OT; Rönnemaa, T; Takala, T; Viikari, JS, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (40.00) | 18.7374 |
| 1990's | 7 (28.00) | 18.2507 |
| 2000's | 7 (28.00) | 29.6817 |
| 2010's | 1 (4.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| De Lorenzo, A | 1 |
| Lima, RS | 1 |
| Capaldo, B | 1 |
| Galderisi, M | 1 |
| Turco, AA | 1 |
| D'Errico, A | 1 |
| Nosso, G | 1 |
| Sidiropulos, M | 1 |
| de Divitiis, O | 1 |
| Riccardi, G | 1 |
| Janatuinen, T | 2 |
| Knuuti, J | 3 |
| Toikka, JO | 1 |
| Ahotupa, M | 1 |
| Nuutila, P | 3 |
| Rönnemaa, T | 3 |
| Raitakari, OT | 3 |
| Sundell, J | 1 |
| Toikka, J | 1 |
| Sultan, A | 1 |
| Piot, C | 1 |
| Mariano-Goulart, D | 1 |
| Daures, JP | 1 |
| Comte, F | 1 |
| Renard, E | 1 |
| Avignon, A | 1 |
| Dankowski, R | 1 |
| Wierzchowiecki, M | 1 |
| Naskret, D | 1 |
| Michalski, M | 1 |
| Kandziora, M | 1 |
| Biegalski, W | 1 |
| Poprawski, K | 1 |
| Amado, JA | 1 |
| Suárez, M | 1 |
| Vadillo, V | 1 |
| Vidal, JI | 1 |
| Mazo, E | 1 |
| Paillole, C | 2 |
| Ruiz, J | 1 |
| Juliard, JM | 2 |
| Leblanc, H | 2 |
| Gourgon, R | 2 |
| Passa, P | 2 |
| Pitkänen, OP | 1 |
| Koskinen, PJ | 1 |
| Iida, H | 1 |
| Lehtimäki, TJ | 1 |
| Laine, HK | 1 |
| Takala, T | 1 |
| Viikari, JS | 1 |
| Fuster, D | 1 |
| Magriñá, J | 1 |
| Ricart, MJ | 1 |
| Pascual, J | 1 |
| Laterza, C | 1 |
| Setoain, FJ | 1 |
| Vidal-Sicart, S | 1 |
| Mateos, JJ | 1 |
| Martín, F | 1 |
| Muxí, A | 1 |
| Baron, BW | 1 |
| Martin, MS | 1 |
| Sucharetza, BS | 1 |
| Jeon, H | 1 |
| Baron, JM | 1 |
| Schernthaner, G | 1 |
| Mühlhauser, I | 1 |
| Silberbauer, K | 1 |
| Zannino, L | 1 |
| Salvadori, G | 1 |
| Eldor, A | 1 |
| Diaz, EG | 1 |
| Naparstek, E | 1 |
| Paycha, F | 1 |
| Steg, PG | 1 |
| Philippe, L | 1 |
| Nesto, RW | 1 |
| Watson, FS | 1 |
| Kowalchuk, GJ | 1 |
| Zarich, SW | 1 |
| Hill, T | 1 |
| Lewis, SM | 1 |
| Lane, SE | 1 |
| Boudreau, RJ | 1 |
| Strony, JT | 1 |
| duCret, RP | 1 |
| Kuni, CC | 1 |
| Wang, Y | 1 |
| Wilson, RF | 1 |
| Schwartz, JS | 1 |
| Castaneda-Zuniga, WR | 1 |
| Avogaro, A | 1 |
| Nosadini, R | 1 |
| Doria, A | 1 |
| Fioretto, P | 1 |
| Velussi, M | 1 |
| Vigorito, C | 1 |
| Saccà, L | 1 |
| Toffolo, G | 1 |
| Cobelli, C | 1 |
| Trevisan, R | 1 |
| Gibb, DM | 1 |
| Dunger, D | 1 |
| Levin, M | 1 |
| Grant, D | 1 |
| Jones, P | 1 |
| Barratt, TM | 1 |
| Hopper, AH | 2 |
| Tindall, H | 2 |
| Davies, JA | 2 |
| Urquhart, S | 1 |
| Aguilar Muñoz, A | 1 |
| de la Cruz Cortés, JP | 1 |
| Martos Crespo, F | 1 |
| García Arnés, J | 1 |
| de Pablo Molina, J | 1 |
| Sánchez de la Cuesta, F | 1 |
| Jones, DB | 1 |
| Haitas, B | 1 |
| Carter, RD | 1 |
| Bown, E | 1 |
| Mann, JI | 1 |
2 reviews available for dipyridamole and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
Four patients with both thrombotic thrombocytopenic purpura and autoimmune thrombocytopenic purpura: the concept of a mixed immune thrombocytopenia syndrome and indications for plasma exchange.
Topics: Adult; Arthritis, Rheumatoid; Aspirin; Autoimmune Diseases; Blood Platelets; Combined Modality Thera | 2001 |
[Platelet aggregation inhibitors. Their possible use in pediatric pathology].
Topics: Age Factors; Anti-Inflammatory Agents; Aspirin; Child; Clofibrate; Dextrans; Diabetes Mellitus, Type | 1979 |
7 trials available for dipyridamole and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
Effect of pravastatin on low-density lipoprotein oxidation and myocardial perfusion in young adults with type 1 diabetes.
Topics: Adult; Coronary Circulation; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Dipyridamole; Double- | 2004 |
Diabetic background retinopathy is associated with impaired coronary vasoreactivity in people with Type 1 diabetes.
Topics: Adult; Autonomic Nervous System; Blood Pressure; Coronary Circulation; Coronary Vessels; Diabetes Me | 2004 |
Absence of effect of dipyridamole on renal and platelet function in diabetes mellitus.
Topics: Adolescent; Albuminuria; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Dipyridamole; Double-Bli | 1990 |
Administration of aspirin-dipyridamole reduces proteinuria in diabetic nephropathy.
Topics: Adult; Aspirin; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Dipyridamole; Double-Blind Method | 1989 |
Effect of aspirin alone and aspirin plus dipyridamole in early diabetic retinopathy. A multicenter randomized controlled clinical trial. The DAMAD Study Group.
Topics: Adult; Aspirin; Blood Pressure; Clinical Trials as Topic; Diabetes Mellitus, Type 1; Diabetes Mellit | 1989 |
Reduction of exercise-induced albuminuria by aspirin-dipyridamole in patients with diabetes mellitus.
Topics: Adult; Albuminuria; Aspirin; Diabetes Mellitus, Type 1; Dipyridamole; Drug Therapy, Combination; Hum | 1987 |
[Effect of dipyridamole (225 mg/day) and acetylsalicylic acid (150 mg/day) on various platelet parameters in non-complicated diabetes mellitus].
Topics: Aspirin; Blood Platelets; Diabetes Mellitus, Type 1; Dipyridamole; Humans; Malondialdehyde; Platelet | 1986 |
16 other studies available for dipyridamole and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
Reduced heart rate response to dipyridamole as a marker of left ventricular dysfunction in diabetic patients undergoing myocardial perfusion scintigraphy.
Topics: Aged; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipyridamole; Female; Heart Rate; Humans | 2009 |
Coronary vasoreactivity is not altered in young people with type 1 diabetes.
Topics: Adult; Analysis of Variance; Blood Pressure; Cardiovascular Diseases; Case-Control Studies; Coronary | 2010 |
Myocardial perfusion imaging and cardiac events in a cohort of asymptomatic patients with diabetes living in southern France.
Topics: Aged; Angina Pectoris; Coronary Disease; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipyr | 2006 |
Association between retinopathy, microalbuminuria and coronary perfusion in young patients with type 1 diabetes mellitus.
Topics: Adolescent; Adult; Albuminuria; Blood Flow Velocity; Coronary Circulation; Coronary Disease; Diabete | 2008 |
[Levels of beta-thromboglobulin in type I diabetes mellitus. Effect of dipyridamole].
Topics: Beta-Globulins; beta-Thromboglobulin; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Dipyridamole | 1983 |
Detection of coronary artery disease in diabetic patients.
Topics: Adult; Aged; Coronary Disease; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiop | 1995 |
Coronary flow reserve is reduced in young men with IDDM.
Topics: Adult; Autonomic Nervous System; Blood Glucose; Coronary Circulation; Coronary Disease; Diabetes Mel | 1998 |
Noninvasive assessment of cardiac risk in type I diabetic patients being evaluated for combined pancreas-kidney transplantation using dipyridamole-MIBI perfusion tomographic scintigraphy.
Topics: Adult; Contraindications; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Dipyridamole; Exercise | 2000 |
Beta-thromboblogulin lowered by dipyridamole in diabetes.
Topics: Beta-Globulins; beta-Thromboglobulin; Depression, Chemical; Diabetes Mellitus, Type 1; Dipyridamole; | 1979 |
Treatment of diabetic necrobiosis with aspirin and dipyridamole.
Topics: Adult; Aspirin; Diabetes Mellitus, Type 1; Dipyridamole; Female; Humans; Necrobiosis Lipoidica | 1978 |
Treatment of diabetic necrobiosis with aspirin or dipyridamole.
Topics: Adolescent; Adult; Animals; Aspirin; Diabetes Complications; Diabetes Mellitus, Type 1; Dipyridamole | 1978 |
Non-invasive identification of severe coronary artery disease in patients with long-standing diabetes mellitus.
Topics: Coronary Angiography; Coronary Disease; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabet | 1992 |
Silent myocardial ischemia and infarction in diabetics with peripheral vascular disease: assessment by dipyridamole thallium-201 scintigraphy.
Topics: Adult; Aged; Aged, 80 and over; Coronary Disease; Diabetes Complications; Diabetes Mellitus; Diabete | 1990 |
Perfusion thallium imaging of type I diabetes patients with end stage renal disease: comparison of oral and intravenous dipyridamole administration.
Topics: Administration, Oral; Adult; Aged; Coronary Angiography; Coronary Disease; Diabetes Mellitus, Type 1 | 1990 |
Myocardial metabolism in insulin-deficient diabetic humans without coronary artery disease.
Topics: Adult; Blood Pressure; Coronary Disease; Diabetes Mellitus, Type 1; Dipyridamole; Echocardiography; | 1990 |
Prostaglandin synthesis inhibition reduces platelet aggregation in diabetes mellitus.
Topics: Aspirin; Diabetes Mellitus, Type 1; Dipyridamole; Humans; Platelet Aggregation; Prostaglandins | 1985 |